GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
93 hedge funds and large institutions have $525M invested in G1 Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 30 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
93
Holding in Top 10
–
Calls
–
Puts
$1K
Top Buyers
| 1 | +$10.7M | |
| 2 | +$9.54M | |
| 3 | +$7.52M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.91M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$6.78M |
Top Sellers
| 1 | -$49.6M | |
| 2 | -$25.4M | |
| 3 | -$24.8M | |
| 4 |
DM
Deerfield Management
New York
|
-$15M |
| 5 |
MCM
Marsico Capital Management
Denver,
Colorado
|
-$10.6M |